Sinofn Health Sinofn Health

Custom SINOFN Health Ubiquinol Vs Ubiquinone Manufacturers & Factories

Precision Manufacturing | Scientific Innovation | Global Supply Chain Resilience

Ubiquinol Vs Ubiquinone: The Science of Bioavailability

In the rapidly evolving landscape of nutraceuticals, the distinction between Ubiquinol and Ubiquinone is not merely academic—it is the cornerstone of clinical efficacy for Coenzyme Q10 (CoQ10) supplementation. As professional manufacturers, SINOFN Health recognizes that informed consumers and brands demand high-grade, bioavailable raw materials.

Understanding the Molecular Gap

CoQ10 exists in two primary forms: oxidized (Ubiquinone) and reduced (Ubiquinol). Ubiquinone serves as the electron carrier in the mitochondrial electron transport chain. However, as we age, the body's natural ability to convert Ubiquinone into the active, antioxidant form—Ubiquinol—diminishes significantly.

The SINOFN Advantage: Our manufacturing processes at SINOFN focus on stabilization technologies that prevent the rapid oxidation of Ubiquinol. By leveraging advanced encapsulation techniques and oxygen-free processing environments, we ensure that the Ubiquinol supplied in our ODM/OEM solutions maintains its integrity from the factory floor to the end consumer’s capsule.

China Factory 4.0: Supply Chain Resilience & Efficiency

The global manufacturing paradigm has shifted. Gone are the days of simple labor-intensive production. SINOFN Health represents the vanguard of "China Factory 4.0," characterized by:

  • Intelligent Manufacturing: Integration of automated feedback loops in production lines to maintain pharmaceutical-grade consistency.
  • Supply Chain Traceability: Utilizing blockchain for raw material sourcing, ensuring every batch of Ubiquinol can be traced back to its origin.
  • Capacity Scalability: With annual capacities exceeding 500 million units, we accommodate startups and multinational corporations with equal efficiency.

Global R&D Excellence

Dr. Tan Shengjie

Medical Innovation Director. Ph.D from Peking University Medical School. 15+ years in metabolic disorder formulations.

Dr. Zhang Ying

R&D Lead. Associate Researcher at Chinese Academy of Sciences (CAS). Specialist in bioactive compound delivery systems.

Hans van Dijk

Formulation Director. Senior Scientist from the Netherlands. Expert in EU regulatory compliance and nutraceutical delivery technology.

53,000㎡
Manufacturing Facility
350M+
Capital Investment
25+
Proprietary Patents
71+
Registered Trademarks

Frequently Asked Questions

What is the difference between your Ubiquinol and Ubiquinone production?

We apply specialized inert gas protection technology during the manufacturing of Ubiquinol to prevent oxidation, ensuring higher bioavailability compared to standard Ubiquinone formulations.

Do you support global regulatory documentation for export?

Yes. With our BRCGS certification and international regulatory team led by Hans van Dijk, we provide full support for US FDA, EU EFSA, and other regional regulatory requirements.

Can SINOFN help with custom formulation development?

Absolutely. Our Tianjin R&D center, in partnership with the Chinese Academy of Sciences, offers pilot-scale prototyping and stability testing to turn your concept into a market-ready product.